Aminophylline Injection, Solution
Product Images NDC 51662-1204

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Aminophylline (NDC 51662-1204). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

0409 5921 16 Aminophylline Vial Label

A 10 mL single-dose vial label for Aminophylline Injection, USP. The label states 250 mg per 10 mL (25 mg/mL) concentration and instructs to protect from light. It includes a warning in red text not to use if crystals have separated from the solution. The label shows the product as distributed by Hospira, Inc.*

FDA Label Image

Serialized Label (51662 1204 Serialized Single Dose Vial)

A 10 mL clear glass vial of Aminophylline Injection, USP with a blue cap. The label on the vial states a concentration of 250 mg per 10 mL (25 mg/mL) for intravenous use. The vial is distributed by HF Acquisition Co LLC, DBA HealthFirst.*

FDA Label Image

5166212042 Label

Label for AMINOPHYLLINE Injection USP, 250 mg (25 mg/mL), 10 mL vial. The label includes NDC 51662-1204-2, a sample lot number and expiration date 2021-06-01. Distributed by HF Acquisition Co., LLC, Mukilteo, WA. The label also contains handling instructions and a QR code.*

FDA Label Image

5166212043 Rfid Label

DataMatrix barcode label for Aminophylline injection, 25 mg/mL, distributed by HF Acquisition Co LLC, Mukilteo, WA. The label includes GTIN, expiration date, lot number, and a barcode for scan verification, along with a note to see the manufacturer's package insert. The label states RX ONLY.*

FDA Label Image

5166212043 Label

Label for AMINOPHYLLINE Injection USP 250 mg (25 mg/mL) in a 10 mL vial, box of 25. The label shows the NDC 51662-1204-3 and lot number ABCDEFGHIJKLMNOPQRST with an expiration date of 2021-06-01. Distributed by HF Acquisition Co., LLC, Mukilteo, WA 98275. The label includes usage instructions and storage conditions.*

FDA Label Image

Adverse (Adverse Event)

A data table comparing signs and symptoms of acute overdose (large single ingestion) and chronic overdosage (multiple excessive doses) from two studies. It categorizes symptoms by system including gastrointestinal, metabolic/other, cardiovascular, and neurologic, reporting occurrences such as vomiting, hypokalemia, sinus tachycardia, tremors, seizures, and death, with some data marked as NR (not reported).*

FDA Label Image

Vial Label (Aminophylline Mfg Label)

Label for Aminophylline Injection, USP 250 mg (25 mg/mL) in a 10 mL single-dose vial. The label states it is for intravenous use, prescription only, and includes storage instructions to protect from light. It also notes the solution pH and sterility information. The label shows the NDC 0409-5921-01 and the labeler Hospira, Inc.*

FDA Label Image

Clinical Pharm Tabel (Clinical Pharm Tabel)

A pharmacokinetic data table showing total body clearance and half-life mean values and ranges of aminophylline by population characteristics including age groups, concurrent illnesses, physiological states, and specific conditions such as liver disease, pregnancy, and thyroid disease.*

FDA Label Image

Dosage 1 (Dosage 1)

A data table showing theophylline infusion rates in mg/kg/hr according to patient population and age groups. Categories include neonates, infants, young children, older children, adolescents (smokers and nonsmokers), adults, elderly, and patients with specific health conditions like cardiac decompensation. Dosage rates vary by age and condition, with numerical values and some equations provided for infants.*

FDA Label Image

Dosage 2 (Dosage 2)

A table presenting dosage adjustment recommendations for AMINOPHYLLINE injection based on peak serum concentration levels, ranging from less than 9.9 mcg/mL to greater than 30 mcg/mL. The table specifies infusion rate changes, monitoring intervals, and actions to take for each concentration range in children and adults.*

FDA Label Image

Supplied (How Supplied)

A data table showing two units of sale for aminophylline injection, solution with a concentration of 25 mg/mL. The first unit is NDC 0409-5921-01 with total strength 250 mg per 10 mL (25 in a carton), and the second unit is NDC 0409-5922-01 with total strength 500 mg per 20 mL (25 in a carton).*

FDA Label Image

Logo (Logo)

FDA Label Image

Precautions 1 (Precautions 1st)

A data table listing drug interactions with theophylline. It includes columns for Drug, Type of Interaction, and Effect, detailing how various drugs increase or decrease theophylline clearance and their clinical impact.*

FDA Label Image

Precautions 2 (Precautions 2)

A partial data table listing various drugs and compounds in two columns, including names such as albuterol, amoxicillin, atenolol, azithromycin, caffeine, diltiazem, famotidine, finasteride, hydrocortisone, isoniazid, ketoconazole, lomefloxacin, mebendazole, methylprednisolone, metronidazole, metoprolol, nadolol, nifedipine, omeprazole, prednisone, ranitidine, rifabutin, roxithromycin, sorbitol, sucralfate, terfenadine, and tetracycline, among others. The table includes some additional notes like "with or without sulbactam" and a parenthetical note about theophylline absorption.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of aminophylline, showing its molecular composition including methyl groups, oxygen, nitrogen atoms, and water of hydration. The structure is displayed with bonds and atoms labeled clearly, representing the active ingredient aminophylline.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.